openPR Logo
Press release

Medos Medizintechnik AG gets a visual makeover

11-08-2011 02:28 PM CET | Health & Medicine

Press release from: Medos Medizintechnik

The changes that came with the company's newly-defined strategic focus are now clearly visible for the world to see.

Medos presented its complete design makeover for the first time at the 25th Annual European Congress of Cardiac and Thoracic Surgeons (EACTS) in Lisbon in early October. The redesign is a logical consequence after the company’s repositioning. "We want Medos’ new, clear strategy to be reflected in our corporate design," says Dr. Jürgen Böhm, member of the executive board.

The revamping of the corporate design goes beyond simple aesthetics – it aims to reflect the company’s new ambition of being a major provider of “cardiopulmonary solutions”. “For us this means that we are embarking on a path of close collaboration with cardiac surgeons and perfusionists to promote innovation and new approaches to therapy. The focus of the new corporate strategy is clearly placed on the users of Medos products as they will greatly influence the planned expansion of our product portfolio. They should see themselves in our new look," said Boehm.

In recent weeks Medos has stated clearly that the company is investing in the expansion of its product portfolio and “will continue to produce the highest Made in Germany quality” according Josef Bogenschütz, member of the executive board. “The absolute priority for us, in addition to continued advancement of technology, is the expansion of our national and international distribution network that will bring our service and support concept to life by intensifying dialogue with our clinical partners and customers,” said Bogenschütz.

The completely redesigned website www.medos-ag.com was recently unveiled and is now available to all customers, users and anyone interested in learning more about the company. Medos seeks to create an information platform that will be a source of information about the company and its products as well as current events and news about the therapy process, scientific publications and much more.

Please send a copy after publication
Contact:

Judith Reiners
Head of Marketing
j.reiners@medos-ag.com
Tel.: +49 2402 9664 26
Fax: +49 2402 9664 60

Medos Medizintechnik AG
Obere Steinfurt 8-10
52222 Stolberg
www.medos-ag.com

Medos AG
Medos AG is a leading German medium-sized high-tech medical device company that develops, manufactures and distributes products worldwide for cardiac surgery and peripheral applications. From its inception, Medos has placed a premium on the quality of development and production in keeping with “Made in Germany”. The facilities in Stolberg and Radeberg manufacture the complete portfolio of cardiac surgery products using advanced technologies. Thousands of patients have already benefited from these products.

The product range features the deltastream® system, individually configurable Medos® tubing sets, hilite® oxygenators and reservoirs, rheoparin® coating (Heparin), and a comprehensive Medos® needle programme which provides the right needle for each individual treatment as well as the Sono TT flow Lab® for intra-operative, non-invasive flow measurement.

Judith Reiners
Head of Marketing
j.reiners@medos-ag.com
Tel.: +49 2402 9664 26
Fax: +49 2402 9664 60

Medos Medizintechnik AG
Obere Steinfurt 8-10
52222 Stolberg
www.medos-ag.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Medos Medizintechnik AG gets a visual makeover here

News-ID: 199576 • Views:

More Releases from Medos Medizintechnik

Medos Medizintechnik AG inaugurates new site
Medos Medizintechnik AG inaugurates new site
Management Board members Dr. Böhm and Mr. Bogenschütz officially inaugurated a new development site in Germany. The inauguration of the new Medos site is a further step forwards in the company's consistent implementation of its defined strategy of creating new technologies and therapeutic concepts. Medos develops, manufactures and markets products and therapies in the field of cardiac surgery for the treatment of heart attacks. The new development department in Reutlingen, Germany, will
Dr. Jürgen Böhm and Josef Bogenschütz complete the line-up of the management board at Medos
Dr. Jürgen Böhm and Josef Bogenschütz complete the line-up of the management …
Medos AG is preparing for the step up to becoming a complete provider in the area of cardiac surgery by recruiting the former Maquet managers Dr. Jürgen Böhm und Josef Bogenschütz. On the 1st August, heart surgeon Dr. Jürgen Böhm and graduate engineer Josef Bogenschütz became members of the management board at Medos Medizintechnik AG and, in so doing, completed the line-up. As a result, there will be a clear focus

More Releases for Stolberg

Cross-Border Tax Consulting Services Market Scope and overview, Growth Opportuni …
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Cross-Border Tax Consulting Services market will undergo major changes. According to the latest research, the market size of the Cross-Border Tax Consulting Services industry in 2021 will increase by USD million compared to 2020, with a growth rate of %. The global Cross-Border Tax Consulting Services industry report provides top-notch qualitative and quantitative information including:
Cross-Border Tax Consulting Services Market 2022: Global Industry Research Repor …
The international Cross-Border Tax Consulting Services Market research study represents a complete assessment of the market and includes essential future predictions, industry certifications and market realities. The research report with key information is a crucial advantage that offers valuable and finite aspects of the Cross-Border Tax Consulting Services market. It gives the idea of its revenue generation into the overall market compared to other sellers in the space. It delivers
Medical device transported to ISS - Determination of vascular stiffness of astro …
Mobil-O-Graph® PWA of German medical device manufacturer I.E.M. deployed in ISS space research on vascular aging Monitor for pulse wave analysis transported to the ISS The Technology from I.E.M. (Stolberg, Germany) and AIT (Austrian Institute of Technology, Wien) are on the International Space Station (ISS) since 4th April. Measurements will start tomorrow. On 2nd April, a Mobil-O-Graph® from I.E.M. with the integrated AIT ARCSolver® algorithm for determining arterial stiffness started to the ISS.
Medos Medizintechnik AG inaugurates new site
Management Board members Dr. Böhm and Mr. Bogenschütz officially inaugurated a new development site in Germany. The inauguration of the new Medos site is a further step forwards in the company's consistent implementation of its defined strategy of creating new technologies and therapeutic concepts. Medos develops, manufactures and markets products and therapies in the field of cardiac surgery for the treatment of heart attacks. The new development department in Reutlingen, Germany, will
Dr. Jürgen Böhm and Josef Bogenschütz complete the line-up of the management …
Medos AG is preparing for the step up to becoming a complete provider in the area of cardiac surgery by recruiting the former Maquet managers Dr. Jürgen Böhm und Josef Bogenschütz. On the 1st August, heart surgeon Dr. Jürgen Böhm and graduate engineer Josef Bogenschütz became members of the management board at Medos Medizintechnik AG and, in so doing, completed the line-up. As a result, there will be a clear focus
Novalung and Medos start cooperation
Due to the acquisition of Medos Medizintechnik AG by the private equity fund Zukunftsfonds Heilbronn (“Future Fund of Heilbronn”) the company will cooperate closely in the future with Novalung GmbH, which is expected to strengthen both medical device companies. The Zukunftsfonds Heilbronn (zfhn) announced that it has acquired Medos Medizintechnik AG from Ventizz Capital Partners Advisory AG. The purchase agreement was signed on January 7, 2011. With this